申请人:GAVIS PHARMACEUTICALS
公开号:US20160376245A1
公开(公告)日:2016-12-29
The present invention is directed to a new impurity of famotidine, process for preparing and isolating it. The invention is further related to analytical methods of its identification, synthesis and characterization.
本发明涉及法莫替丁的一种新杂质,其制备和分离的过程。该发明还涉及其鉴定、合成和表征的分析方法。